MBXBF (Microbix Biosystems) Institutional Ownership: 0.22% (As of Jul. 13, 2026)


MBXBF Microbix Biosystems Inc MBXBF
51 GF Score
Price $0.22
GF Value $0.19
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is Microbix Biosystems Institutional Ownership?

Microbix Biosystems MBXBF 51 Institutional Ownership is 0.22% as of Jul. 13, 2026. GuruFocus rates MBXBF with a GF Score™ of 51/100 and a GF Value™ of $0.19 (Modestly Overvalued). The stock has 8 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Microbix Biosystems's institutional ownership is 0.22%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Microbix Biosystems's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Microbix Biosystems's Float Percentage Of Total Shares Outstanding is 0.00%.

Microbix Biosystems Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Microbix Biosystems's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Microbix Biosystems Institutional Ownership Chart

Microbix Biosystems Historical Data

The historical data trend for Microbix Biosystems can be seen below:

2021-05-31 2021-06-30 2021-07-31 2021-08-31 2021-09-30 2021-10-31 2021-11-30 2021-12-31 2022-01-31 2022-02-28
Institutional Ownership 2.54 2.49 2.49 2.49 2.44 2.38 2.38 2.52 0.22 0.22
MBXBF
51GF Score
Microbix Biosystems Inc MBXBF
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Microbix Biosystems Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.22% mean?
Microbix Biosystems (MBXBF) has a Institutional Ownership of 0.22% as of Jul. 13, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Microbix Biosystems and its competitors.
Is Microbix Biosystems' Institutional Ownership too high?
Microbix Biosystems' current Institutional Ownership is 0.22%. Overall, Microbix Biosystems has a GF Score™ of 51/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Microbix Biosystems' Institutional Ownership compare to VRTX and REGN?
Microbix Biosystems' Institutional Ownership of 0.22% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Microbix Biosystems and its competitors. Microbix Biosystems's current Institutional Ownership is 0.22%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Microbix Biosystems stock overvalued right now?
Based on GuruFocus' analysis, Microbix Biosystems (MBXBF) is currently considered Modestly Overvalued. The stock's GF Value™ is $0.19, compared to a current price of $0.22 — trading 13.2% above its estimated fair value. The current Institutional Ownership is 0.22%. Microbix Biosystems' overall GF Score™ is 51/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Microbix Biosystems (MBXBF), the current Institutional Ownership is 0.22% as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Microbix Biosystems (MBXBF) Overvalued in 2026?

Based on GuruFocus' analysis, Microbix Biosystems stock appears to be overvalued. The current stock price of $0.22 is trading 13.2% above its estimated GF Value™ of $0.19. GuruFocus considers Microbix Biosystems to be Modestly Overvalued.

Key valuation signals for MBXBF:

  • Institutional Ownership: 0.22%
  • GF Value™: $0.19 vs. price of $0.22 (13.2% above fair value)
  • GF Score™: 51/100 with 8 warning signs

No single metric tells the full story. See the MBXBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Microbix Biosystems Business Description

Other Exchanges MBX:Canada
Address 265 Watline Avenue, Mississauga, ON, CAN, L4Z 1P3
Microbix Biosystems Inc develops biological products and technologies. There are two operating segments: The development, manufacturing, and sale of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows, and viral transport medium to enable collection of patient test samples; and the development and commercialization of novel and proprietary products or technologies such as Kinlytic. Geographically, it derives a majority of revenue from North America and also operates in Europe and other foreign countries.
51GF Score

Get the complete analysis for MBXBF

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.22
Price
$0.19
GF Value